Acumen Pharmaceuticals, Inc. earnings per share and revenue

ABOS earnings per share for the last quarter are -0.50 USD whereas the estimation was -0.36 USD which accounts for -38.22% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -0.46 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of ABOS earnings per share and revenue dynamics.